Hannah Joseph Hospital IPO GMP Today, Review & Verdict
₹67 – ₹70
Live Market Desk – 6 February Update:
Grey Market Premium remains muted at ₹0–₹1, indicating cautious market sentiment around the issue. Early subscription trends are weak across all investor categories, suggesting limited immediate institutional interest.
Healthcare SME IPOs typically witness stronger demand toward the final day, as investors wait for clearer subscription signals and pricing comfort.
Capital Flow Insight:
If total subscription moves into the 2.5×–4× range by the close, listing sentiment could improve. Otherwise, the issue may see a flat to marginal listing.
Grey Market Signal:
-
GMP: ₹0–₹1
-
Estimated Listing Price: ₹70–₹71
-
Expected Listing Gain: 0%–2%
📊 IPO Snapshot
| Issue Type | SME IPO – Fresh Issue |
| Issue Size | ₹39.90 Crore |
| Fresh Shares | ~5,70,000 Shares |
| Price Band | ₹67 – ₹70 |
| Lot Size | 2,000 Shares |
| Minimum Investment | ₹1,40,000 |
| Exchange | BSE SME |
| Registrar | Bigshare Services Pvt Ltd |
| Lead Manager | Beeline Capital Advisors Pvt Ltd |
| Post-IPO Market Cap | ₹145 – ₹155 Crore (Estimated) |
📅 IPO Timeline
| Opening Date | 22 Jan 2026 |
| Closing Date | 27 Jan 2026 |
| Allotment Date | 28 Jan 2026 |
| Refund Date | 29 Jan 2026 |
| Demat Credit | 30 Jan 2026 |
| Listing Date | 30 Jan 2026 (Expected) |
📊 Subscription Status (Live)
| Category | Subscription | Shares Offered | Shares Bid |
|---|---|---|---|
| Retail | 0.04x | 1,99,500 | 7,980 |
| NII / HNI | 0.24x | 85,500 | 20,520 |
| QIB | 0.00x | 2,85,000 | 0 |
| Total | 0.07x | 5,70,000 | 28,500 |
🏥 Company Overview
💰 Use of IPO Proceeds
- Hospital infrastructure expansion
- Medical equipment purchase
- Working capital
- Debt repayment
| Pre-IPO Promoter Holding | 100% |
| Post-IPO Promoter Holding (Est.) | ~73% – 75% |
| Public Shareholding | ~25% – 27% |
💰 Financial Performance (₹ Cr)
| Year | Revenue | PAT | EBITDA Margin |
|---|---|---|---|
| FY2023 | 52.3 | 2.14 | 21.4% |
| FY2024 | 64.8 | 3.06 | 22.6% |
| FY2025 | 78.9 | 4.12 | 23.8% |
📊 Balance Sheet Snapshot (FY25)
| Total Assets | ₹142 Cr |
| Net Worth | ₹56 Cr |
| Total Debt | ₹41 Cr |
💵 Cash Flow Snapshot (FY25)
| Operating Cash Flow | ₹6.1 Cr |
| Investing Cash Flow | -₹4.6 Cr |
| Financing Cash Flow | ₹3.2 Cr |
📊 Valuation Metrics
| EPS (Post IPO) | ₹4.7 – ₹5.0 |
| P/E Ratio | ~14x – 15x |
| ROE | 22% – 24% |
| Debt to Equity | 0.70 – 0.80 |
🎯 Listing Scenario Model
| Bear Case | ₹65 – ₹69 |
| Base Case | ₹70 – ₹74 |
| Bull Case | ₹75 – ₹82 |
⚖️ Risk vs Reward Matrix
| Listing Gain Probability | 25% – 40% |
| Flat Listing Probability | 40% – 50% |
| Loss Probability | 15% – 25% |
🏁 Final Verdict
- Listing traders: Apply selectively
- High-risk investors: Small exposure only
- Conservative investors: Avoid
Shubham Chaudhary is the founder of PositionalCalls, an independent Indian stock market research website. He writes company fundamentals, quarterly results analysis, IPO analysis and sector research for NSE and BSE listed companies, with a focus on banking stocks, insurance and long-term value investing. Every article is built from primary sources such as exchange filings, SEBI offer documents and annual reports, and states its risks plainly, in simple language for retail investors.
Coverage areas
Our research standards
- Numbers checked against NSE, BSE and SEBI filings
- Risks and limits stated in every article
- No paid promotions or broker tie-ups
- Articles updated when new filings arrive
Disclosure: The author is not a SEBI-registered investment adviser. Content is for education and information only and is not investment advice or a recommendation to buy or sell any security. Investments are subject to market risks; consult a SEBI-registered adviser before investing.